RBC Capital Upgrades ICON PLC to Buy, Targets $185

RBC Capital upgraded ICON PLC to a buy rating with a $185 price target, a 8.91% upside from the current price.

Key Points

  • RBC Capital upgraded ICON PLC (ICLR) to a buy rating on June 25, 2026, with a new price target of $185.
  • RBC Capital's $185 price target implies 8.91% upside from ICON Public Limited Company's ($ICLR) current $169.86 share price.
  • Shares of ICON PLC traded at $158.17 on Thursday, with a market cap of about $10.78 billion and a 52-week range of $66.57 to $211.00.
  • Peers like Artisan Partners and Wellington Management have also increased their holdings in ICON PLC recently.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

ICON Public Limited Company (NasdaqGS: ICLR) received an upgrade from RBC Capital on June 25, 2026. Analyst Ryan Halsted raised the rating to a 'buy' and set a new price target of $185. As of Thursday, the stock was trading at $158.17.

Analyst rating track record

RBC Capital vs. the S&P 500

YTD return +5.59% hypothetical
All-time return +9.32% S&P 500 +28.91%
vs. S&P 500 -19.59% behind the index

Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.

Other Institutional Activity in ICON PLC

Artisan Partners Limited Partnership increased its holdings in ICON PLC by 1,404,968 shares, reaching a total of 8,278,945 shares valued at approximately $916.1 million, marking a 20.4% increase. Wellington Management Group LLP also boosted its position by 1,562,287 shares, ending with 5,913,037 shares worth about $654.3 million, a 35.9% increase. Harris Associates L.P. made a significant move by adding 1,841,151 shares, raising its total to 4,351,317 shares valued at $481.5 million, a 73.3% increase. FMR LLC saw a 34.7% increase in its holdings, adding 1,076,111 shares to reach 4,174,006 shares worth around $461.9 million. Meanwhile, Invesco Ltd. increased its stake by 121,973 shares to hold 3,878,869 shares valued at $429.2 million, a 3.2% rise.

ICON Public Limited Company Stock Down 0.1%

On Thursday, ICON PLC's shares traded at $158.17. The company, with a market cap of approximately $10.78 billion, has a P/E ratio of 48.36 and a forward P/E of 12.03. Its beta is 1.271, indicating moderate volatility. The stock's 52-week range spans from $66.57 to $211.00, with a 50-day moving average of $124.49 and a 200-day moving average of $149.71. ICON's current ratio is 1.096, and its quick ratio is 1.063, showing a solid liquidity position.

12-month forecast

$ICLR price target

Past daily closes and this analyst's 12-month price target. Not investment advice.

Recent Earnings

ICON PLC reported revenue of approximately $8.25 billion, with a revenue growth rate of 12.4%. The company's net margin stands at 2.78%, and it reported an EPS of $2.91. Return on equity is 2.46%. The next earnings report is expected on June 23, 2026.

Insider Buying and Selling at ICON Public Limited Company

On May 14, 2026, insider transactions at ICON PLC included both purchases and sales. Dr. John Climax bought and sold 5,005 shares, while Ronan Martin Murphy also executed similar transactions with 5,005 shares. Eugene Pacelli McCague bought and sold 3,255 shares on the same day.

Analysts Set New Price Targets

On June 25, 2026, several analysts issued new ratings and price targets for ICON PLC. Barclays maintained a 'hold' rating with a $175 target, while RBC Capital upgraded to a 'buy' with a $185 target. TD Cowen maintained a 'buy' rating, setting a target of $197. JP Morgan maintained a 'hold' with a $155 target, and Evercore ISI Group maintained a 'buy' with a $180 target. B of A Securities maintained a 'sell' with a $150 target, and Baird maintained a 'buy' with a $186 target. The consensus rating remains a 'buy', with a mean target price of $154.19 from 16 analysts.

About ICON Public Limited Company

ICON Public Limited Company is a leading clinical research organization headquartered in Dublin, Ireland. The company provides a range of outsourced development and commercialization services, including clinical trials and laboratory services, to pharmaceutical, biotechnology, and medical device industries worldwide. Led by CEO Barry Balfe, ICON employs approximately 40,100 people and operates in various regions, including Europe and the United States.

Bottom Line

RBC Capital's upgrade of ICON PLC to a 'buy' with a $185 price target reflects positive sentiment on the stock. Investors are closely watching ICON due to its strategic role in the healthcare sector and its recent institutional interest. The upgrade is based on analysis as of the rating date and may not reflect the latest market conditions.

Get ICON Public Limited Company alerts

New 13F filings, insider trades, and analyst moves on $ICLR, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.